About: Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $70.33 (-4.51%)
INBX NASDAQ Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. share price
INBX price activity
Last Price
$69.560
Change (24hr)
-4.09 USD (5.55%)
Volume
150.51K
Volume (4w avg)
-
Open
$72.04
Day Range
$67.54 - $73.03
Previous Close
$73.65
Last Trade
30 Oct, 4:07 pm GMT+0
Delayed
30 Oct, 4:07 pm GMT+0
INBX price performance
Delayed
30 Oct, 4:07 pm GMT+0
INBX Market Signals